Recent study show weight loss injections result in greater weight reduction in women than men, with women losing up to 28% of ...

Eli Lilly plans to pursue approval for its new GLP-1 pill by the end of this year. Fact checked by Nick Blackmer A daily pill ...

A head-to-head trial found that tirzepatide led to significantly greater weight loss and waist reduction than semaglutide in ...

Tirzepatide slashed weight by 20%, leading researchers to call this a new “golden age” for weight-loss therapies.

The effects they have on your body and mind vary, as Wegovy flips one appetite switch in your brain, while Mounjaro flips two ...

Tirzepatide (Zepbound) led to more weight loss than semaglutide (Wegovy) in a clinical trial funded by Eli Lilly.

A weekly dose of semaglutide, a drug used to manage diabetes and weight loss, was effective in 63% of patients at treating a ...

Federal regulators have accepted Novo Nordisk’s application to produce a pill version of its injectable weight-loss ...

While the primary target for these medication is weight loss, it’s not the only metric by which the drugs should be evaluated ...

The analysis of 11 weight-loss drug studies by the University of Oxford found that patients typically lost 8kg (18lb) after ...

This comprehensive review explores MEDVi, a leading telehealth provider offering compounded GLP-1 weight loss solutions like Semaglutide and Tirzepatide in both injection and tablet form.